Jakub Brodowski

Jakub Brodowski

Auto-generated profile, based on publicly available information

Jakub Brodowski


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Quality in Sport
Verified
Journal Article
Open access
KPKlaudia Martyna Patrzykąt
Klaudia Martyna Patrzykąt
KPKonrad Puchalski
Konrad Puchalski
PLPaweł Liszka
Paweł Liszka
JPJakub Perediatkiewicz
Jakub Perediatkiewicz
MZMarta Zasiadła
Marta Zasiadła
AOAgata Ogórek
Agata Ogórek
Background. Acne vulgaris is a chronic inflammatory skin condition that often leads to scarring and psychological distress. Oral isotretinoin is the most effective systemic medication for severe or treatment-resistant acne, but concerns about its adverse effects remain. Aim. This review summarizes the current state of knowledge on isotretinoin in acne therapy, highlighting safety issues and implications for everyday clinical practice. Material and methods. A narrative literature review was conducted using PubMed/MEDLINE for articles published between January 2016 and November 2025. Human studies and reviews on systemic isotretinoin for acne vulgaris treatment, along with selected articles providing relevant epidemiological and clinical context for acne, were included if they reported efficacy, remission, adverse effects, impact on tissue regeneration, or monitoring recommendations. Randomized trials, observational studies, systematic reviews, meta-analyses, and high-quality narrative reviews were eligible for inclusion. Non-acne indications, animal-only studies, and non-peer-reviewed publications were excluded. Results. Isotretinoin addresses all major pathogenic mechanisms of acne, leading to high clearance and long-term remissions. Mucocutaneous dryness is the most common adverse effect, but it is manageable with proper skincare. Laboratory abnormalities involve mild, reversible dyslipidemia and liver enzyme elevations. The most dangerous side effect is teratogenicity, which requires strict pregnancy-prevention programs. Studies have not confirmed an increased incidence of depression or inflammatory bowel disease; however, clinical monitoring remains essential. Musculoskeletal and ophthalmologic adverse effects are generally mild and dose-dependent. Conclusions. Structured risk management, regular clinical and laboratory checks, along with the lowest possible dose, enable safe and effective acne control through individualized isotretinoin treatment.

26 December 2025 in Quality in Sport
Verified
Journal Article
Open access
AOAgata Ogorek
Agata Ogorek
MZMarta Zasiadła
Marta Zasiadła
PLPaweł Liszka
Paweł Liszka
KPKlaudia Martyna Parzykąt
Klaudia Martyna Parzykąt
KOKlaudia Maria Olejnik-Chlewicka
Klaudia Maria Olejnik-Chlewicka
JBJakub Brodowski
Jakub Brodowski
Purpose: The aim of this review is to synthesize existing literature regarding the neuropharmacological effects and potential drug interactions of the most commonly used adaptogens: Withania somnifera and Rhodiola rosea; and develop practical guidelines for the safe use of these supplements with psychotropic medications. Methods: This narrative review examined clinical, observational, and mechanistic studies regarding Ashwagandha and Rhodiola that were identified through a search of PubMed, Cochrane and ScienceDirect between 2013 and 2024. Results: Ashwagandha has been shown to have significant anxiolytic and stress reducing effects, and has a relatively favorable pharmacokinetic profile. However, it has GABAergic activity which can lead to pharmacodynamic interactions with benzodiazepines, z-drugs, and other central nervous system depressants. Rhodiola, on the other hand, has been shown to have activating and antidepressant-like effects, and has been found to modulate monoaminergic transmission, as well as inhibit the activity of cytochrome P450 enzymes CYP2D6 and CYP3A4. These findings suggest that Rhodiola may increase the risk of serotonin toxicity when combined with certain psychotropic medications, and potentially increase the plasma concentrations of co-administered psychotropics due to decreased metabolic clearance. Conclusions: Based on the findings of this review, both Ashwagandha and Rhodiola cannot be viewed as pharmacologically inert supplements that can be safely used in conjunction with prescription medications for the treatment of psychiatric disorders. Therefore, they should be carefully assessed prior to initiating therapy, with consideration of the individual's concurrent prescription medications and comorbid medical conditions. Furthermore, they should be initiated at low doses and monitored closely for symptoms of sedation, serotonergic effects, and signs of drug accumulation.

27 January 2026 in Quality in Sport
Verified
Journal Article
Open access
KOKlaudia Olejnik-Chlewicka
Klaudia Olejnik-Chlewicka
KPKonrad Puchalski
Konrad Puchalski
PLPaweł Liszka
Paweł Liszka
JPJakub Perediatkiewicz
Jakub Perediatkiewicz
MZMarta Zasiadła
Marta Zasiadła
AOAgata Ogórek
Agata Ogórek
Informations and purpose: Parabens are widely used preservatives found in cosmetics, pharmaceuticals, foods and household products. Increasing evidence shows that women of reproductive age, including pregnant women, are consistently exposed to these endocrine-disrupting chemicals, which may influence fetal and early-life development. Understanding exposure levels and potential health consequences is important for both public health and clinical practice. Methods: A systematic literature search was performed to identify studies evaluating paraben exposure during pregnancy and its effects on fetal and early childhood health. The literature search included studies published from 2019-2024 and contained searches of PubMed, Scopus, Science Direct and open access databases. Results: Parabens are widely detected in maternal and fetal matrices. Exposure to parabens in utero has been shown to result in changes to fetal size, metabolic and hormone-related factors and an increased risk of developing atopic and respiratory diseases in early childhood.Reported mechanisms involve endocrine disruption(specifically acting like estrogens and anti-androgens), oxidative stress, immune modulation and possible epigenetic effects. Conclusion: Current evidence indicates that parabens may influence child development through several biological pathways, with effects observable from fetal life into early childhood. Although causality remains to be fully established, reducing paraben exposure in pregnancy and early life—particularly from cosmetic and dermal sources—appears advisable. Public health measures promoting informed consumer choices may further mitigate exposure.